SCHEMBL22013568

SCHEMBL22013568

CN=S(C)(=O)c1cccc(CN(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.43
NPC1 O15118 1/20 0.43
TNF P01375 1/20 0.43
RAB9A P51151 1/20 0.43
NOD1 Q9Y239 1/20 0.43
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
DRD2 P14416 1/20 0.38
HTR2A P28223 1/20 0.38
HTR7 P34969 2/20 0.37
RORC P51449 1/20 0.37
HTR6 P50406 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CASP3 P42574 1/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
HPGD P15428 1/20 0.35
CA2 P00918 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22013565 0.83 NPC1 (0.47) NOS1NPC1TNFRAB9ANOD1
SCHEMBL23665769 0.80 ENPP2 (0.46) NOS1NPC1TNFRAB9ANOD1
SCHEMBL20533585 0.80 HTR6 (0.46) NOS1NPC1TNFRAB9ANOD1
SCHEMBL22002789 0.78 CA2 (0.55) NOS1NPC1TNFRAB9ANOD1
SCHEMBL21893020 0.75 NOS1 (0.44) NOS1NPC1TNFRAB9ANOD1
SCHEMBL14025594 0.73 TAS2R14 (0.60) ALDH1A1TSHRHTR2ACA2MEN1
SCHEMBL989636 0.72 ALDH1A1 (0.67) NOS1ALDH1A1TSHRHTR7HPGD
SCHEMBL20533666 0.71 KMT2A (0.50) TSHRCASP3HPGDCA2MEN1
SCHEMBL23356399 0.70 LMNA (0.59) ALDH1A1TSHRHTR6CA2
SCHEMBL31755421 0.70 LMNA (0.59) ALDH1A1TSHRHTR6CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102576-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed